drugset / Trial / NCT03627130

The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy

NCT03627130

Phase 2 Completed 640 enrolled Barts & The London NHS Trust
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Contrast-induced nephropathy (CIN), an acute kidney injury resulting from the administration of intravascular iodinated contrast media, is an important cause of morbidity/mortality following coronary angiographic procedures in high-risk patients. Despite preventative measures intended to mitigate the risk of CIN, there remains a need for an effective intervention. Dietary inorganic nitrate therapy, which through its chemical reduction in the body delivers nitric oxide has shown promise in attenuating CIN, but its effectiveness in preserving long-term renal function is unknown.

Timeline

Start
2018-11-29
Primary completion
2022-05-30
Completion
2022-05-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Potassium Nitrate Other / unclassified 12 mmol